Precigen (PGEN) financial statements
Precigen reported revenue of $10M in fiscal 2025, down 28.2% a year over 9 years.
Net income was -$251M and the operating margin -1141.1%, against -65.6% in 2016.
Free cash flow was -$90M.
The diluted share count rose 165% over the period (dilution).
Revenue and free cash flow
Fiscal years, $ billions.
Income statement
Fiscal years, from Precigen's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $191M | $219M | $151M | $91M | $32M | $14M | $27M | $6M | $4M | $10M |
| Cost of revenue | $38M | $33M | — | — | — | — | — | — | — | — |
| Gross profit | $153M | $186M | — | — | — | — | — | — | — | — |
| Research and development | $112M | $143M | $405M | — | — | — | — | $49M | $53M | $41M |
| Selling, general and admin | $142M | $146M | $138M | — | — | — | — | $40M | $41M | $70M |
| Operating income | -$125M | -$138M | -$506M | — | — | — | — | -$100M | -$135M | -$111M |
| Interest expense | $861,000 | $611,000 | $9M | — | — | — | — | $468,000 | $6,000 | $4M |
| Pre-tax income | -$194M | -$78M | -$396M | -$171M | -$105M | -$111M | -$80M | -$96M | -$128M | -$251M |
| Income tax | -$4M | $2M | -$15M | -$930,000 | -$82,000 | -$160,000 | -$189,000 | -$458,000 | -$2M | $3,000 |
| Net income | -$187M | -$117M | -$509M | -$322M | -$171M | -$92M | $28M | -$96M | -$126M | -$251M |
| EPS (diluted) | -$1.58 | -$0.98 | -$3.93 | -$2.09 | -$1.02 | -$0.47 | $0.14 | -$0.39 | -$0.47 | -$1.37 |
| Diluted shares | 118M | 120M | 130M | 154M | 167M | 198M | 200M | 245M | 268M | 313M |
| Gross margin | 80.2% | 84.8% | — | — | — | — | — | — | — | — |
| Operating margin | -65.6% | -62.8% | -334.4% | — | — | — | — | -1602.5% | -3440.2% | -1141.1% |
| Net margin | -97.7% | -53.3% | -336.9% | -355.3% | -533.0% | -646.0% | 105.2% | -1540.6% | -3216.2% | -2588.2% |
Balance sheet
Fiscal years, from Precigen's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $237M | $74M | $222M | $75M | $100M | $109M | $56M | $63M | $98M | $100M |
| Receivables | $22M | $20M | $21M | $21M | $16M | $1M | $978,000 | $902,000 | $926,000 | $4M |
| Total current assets | $315M | $154M | $285M | $235M | $149M | $157M | $118M | $69M | $102M | $115M |
| Property, plant and equipment | $65M | $113M | $87M | $44M | $35M | $9M | $7M | $7M | $14M | $14M |
| Goodwill | $157M | $94M | $94M | $54M | $54M | $38M | $37M | $27M | $19M | $15M |
| Total assets | $949M | $847M | $716M | $456M | $315M | $360M | $216M | $151M | $145M | $156M |
| Total current liabilities | $95M | $80M | $62M | $123M | $42M | $35M | $79M | $23M | $22M | $37M |
| Long-term debt | $8M | $8M | $211M | $186M | $172M | $180M | $0 | — | $0 | $93M |
| Total liabilities | $380M | $300M | $337M | $384M | $247M | $253M | $90M | $33M | $79M | $135M |
| Shareholders' equity | $560M | $534M | $363M | $72M | $67M | $107M | $126M | $118M | $39M | $21M |
| Net debt | -$55M | -$60M | $115M | $152M | $120M | $144M | $38M | -$8M | -$30M | $63M |
Cash flow
Fiscal years, from Precigen's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$49M | -$104M | -$124M | -$136M | -$77M | -$56M | -$65M | -$67M | -$68M | -$88M |
| Capital spending | $32M | $47M | $42M | $38M | $8M | $7M | $5M | $2M | $9M | $2M |
| Free cash flow | -$81M | -$150M | -$166M | -$174M | -$85M | -$63M | -$70M | -$68M | -$77M | -$90M |
| Stock-based compensation | $42M | $42M | $36M | $19M | $18M | $14M | $10M | $10M | $9M | $11M |
| Net borrowing | -$654,000 | -$194,000 | $219M | -$242,000 | -$490,000 | -$466,000 | -$155M | -$43M | $0 | $93M |
| Free cash flow margin | -42.2% | -68.5% | -109.7% | -191.6% | -264.3% | -441.7% | -260.0% | -1099.9% | -1955.6% | -927.6% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for PGEN.
Open PGEN in InvestinglyQuestions
What was Precigen's revenue in 2025?
$10M in fiscal 2025, from its 10-K filing.
How much free cash flow does Precigen generate?
-$90M in fiscal 2025 (operating cash flow minus capital spending).
From Precigen's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.